Literature DB >> 12857718

Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.

Yusheng Qiu1, Jie Zhu, Venkata Bandi, Robert L Atmar, Keith Hattotuwa, Kay K Guntupalli, Peter K Jeffery.   

Abstract

We have applied immunohistology and in situ hybridization to bronchial biopsies of patients with chronic obstructive pulmonary disease (COPD) to examine neutrophil recruitment and to determine neutrophil chemoattractant and CXC receptor (CXCR) 1 and CXCR2 gene expression associated with acute severe exacerbations. Cells were counted in endobronchial biopsies of (1) patients with COPD intubated for exacerbations (E-COPD; n = 15), (2) those with COPD in a stable phase of their disease (S-COPD; n = 7), and (3) nonsmoker surgical control subjects intubated for a nonrespiratory surgical procedure (n = 15). In comparison with the nonrespiratory surgical procedure and S-COPD groups, neutrophilia and gene expression for epithelial-derived neutrophil attractant-78 (CXCL5), interleukin-8 (CXCL8), CXCR1, and CXCR2 were each upregulated in the E-COPD group (p < 0.01); compared with the S-COPD group, by 97-, 6-, 6-, 3-, and 7-fold, respectively (p < 0.01). In E-COPD, there was a significant positive association between the number of neutrophils and CXCR2 mRNA-positive cells (r = 0.79; p < 0.01) but not between the number of neutrophils and CXCR1 mRNA-positive cells. At the time of sampling of the mucosa, there was no association between neutrophil number and either the length of intubation or viral infection. Thus, in COPD, in addition to CXCL8 and CXCR1, CXCL5 and CXCR2 appear to play important roles in the airway neutrophilia characteristic of severe exacerbations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857718     DOI: 10.1164/rccm.200208-794OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  119 in total

1.  CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection.

Authors:  Junjie Mei; Yuhong Liu; Ning Dai; Michael Favara; Teshell Greene; Samithamby Jeyaseelan; Mortimer Poncz; Janet S Lee; G Scott Worthen
Journal:  Immunity       Date:  2010-07-23       Impact factor: 31.745

Review 2.  The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.

Authors:  Antonio Citro; Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

3.  Modulation of airway inflammation by Haemophilus influenzae isolates associated with chronic obstructive pulmonary disease exacerbation.

Authors:  Dwight C Look; Cecilia L Chin; Lori J Manzel; Erin E Lehman; Alicia L Humlicek; Lei Shi; Timothy D Starner; Gerene M Denning; Timothy F Murphy; Sanjay Sethi
Journal:  Proc Am Thorac Soc       Date:  2006-08

4.  The elevated CXCL5 levels in circulation are associated with lung function decline in COPD patients and cigarette smoking-induced mouse model of COPD.

Authors:  Jun Chen; Luqi Dai; Tao Wang; Junyun He; Yashu Wang; Fuqiang Wen
Journal:  Ann Med       Date:  2019-07-16       Impact factor: 4.709

5.  The laws of attraction: chemokines, neutrophils and eosinophils in severe exacerbations of asthma.

Authors:  Graziella Turato; Simonetta Baraldo; Renzo Zuin; Marina Saetta
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

6.  CXCL5 overexpression is associated with late stage gastric cancer.

Authors:  Jeong Youp Park; Kyung Hwa Park; Seungmin Bang; Myoung Hwan Kim; Ji-Eun Lee; Jingu Gang; Sang Seok Koh; Si Young Song
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-04       Impact factor: 4.553

Review 7.  CXCR2: a target for pancreatic cancer treatment?

Authors:  Kathleen M Hertzer; Graham W Donald; O Joe Hines
Journal:  Expert Opin Ther Targets       Date:  2013-02-21       Impact factor: 6.902

Review 8.  The cytokine network in asthma and chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

9.  Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.

Authors:  Jennifer K Quint; Gavin C Donaldson; James J P Goldring; Ramin Baghai-Ravary; John R Hurst; Jadwiga A Wedzicha
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

Review 10.  The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Authors:  Richard Hewitt; Hugo Farne; Andrew Ritchie; Emma Luke; Sebastian L Johnston; Patrick Mallia
Journal:  Ther Adv Respir Dis       Date:  2015-11-26       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.